Network Performance Report
1,248
Patients Matched
+18%1,248
Patients Matched
+18%1,248
Patients Matched
+18%1,248
Patients Matched
+18%The Active Conditions
Johnson & Johnson’s 70 active trials span 45 conditions listed below. Numbers in parentheses indicate active trial counts per condition.
Multiple myeloma 15
Lung cancer 10
Colorectal cancer 7
Prostate cancer 7
Breast Cancer 6
Leukemia 6
Ovarian Cancer 5
Lymphoma 5
Pancreatic Cancer 4
Kidney Cancer 5
Gastric Cancer 4
Gastric Cancer 8
Melanoma 6
Bladder Cancerr 2
Cervical Cancer 8
Endometrial Cancer 7
Liver Cancer 3
Brain Tumors 1
Esophageal Cancer 2
Sarcoma 9
Activity Summary
Summary of Activity in February 2026
Trial Page Views 151
Patients Matched for Referral 298
Trials with Matched Patients 34
Total Potential Referrals 595
Summary of Activity in February 2024
Trial Page Views 991
Patients Matched for Referral 4,893
Trials with Matched Patients 70
Total Potential Referrals 10,083
Legend / Notes
Patients Matched for Referral:
Counts the number of unique patients that matched to one or more [J&J] trials and were thus potentially eligible for referral.
Trials with Matched Patients:
Counts the number of [J&J] trials that had one or more patients that matched.
Total Potential Referrals:
Indicates all potential patient-referral combinations and can include multiple potential referrals for the same patient if they matched to more than one trial.
Detailed Referral Activity?
Head and Neck Cancer:
Completed questionnaires for head and neck cancer 19
Matched to a sponsor trial and eligible for referral. 17
Total Potential Referrals for each instance. 34
Head and Neck Cancer:
Completed questionnaires for head and neck cancer 19
Matched to a sponsor trial and eligible for referral. 17
Total Potential Referrals for each instance. 34
Head and Neck Cancer:
Completed questionnaires for head and neck cancer 312
Matched to a sponsor trial and eligible for referral. 192
Total Potential Referrals for each instance. 346
Head and Neck Cancer:
Completed questionnaires for head and neck cancer 220
Matched to a sponsor trial and eligible for referral. 105
Total Potential Referrals for each instance. 349
Network Partners Featuring [J&J] Trials
[J&J] active trials are displayed on the below [50] Carebox Connect Network partners’ websites. Click on the logo to visit the partner’s Carebox Connect clinical trial finder.
Carebox Connect Network Intelligence Reports for [J&J] Trials
Gain additional deeper insight into how each of [J&J]’s clinical trials have performed across the Carebox Connect Network of more than 50 advocacy group partners. Each link below allows you to complete a short form and receive an email-delivered trial-specific report summarizing network exposure, patient engagement, eligibility-based matching activity, geographical distribution of potential referrals, recruitment barriers, and competitive context—all based on actual real-world patient interactions.
KEYNOTE-789: Pembrolizumab in NSCLC
NCT04538378
KEYNOTE-789: Pembrolizumab in NSCLC
NCT04538378
KEYNOTE-789: Pembrolizumab in NSCLC
NCT04538378
KEYNOTE-789: Pembrolizumab in NSCLC
NCT04538378